EPISODE · Jan 31, 2020 · 4 MIN
Anti-TNFα therapy and risk of cancer in patients with immune-mediated diseases
from Listen to The Lancet Gastroenterology & Hepatology · host The Lancet
Dr Akbar Waljee discusses findings from a cohort study investigating the risk of cancer recurrence or a new primary cancer in patients with IBD, rheumatoid arthritis, or psoriasis who received anti-TNFα therapy.
NOW PLAYING
Anti-TNFα therapy and risk of cancer in patients with immune-mediated diseases
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m